On October 27, Shaperon announced that CEO Sung Seungyong has been invited as a keynote speaker at the 7th Inflammasome Therapeutics Summit, which ...

After entering into a definitive agreement to acquire CureVac—who focuses on mRNA-based medicines for oncology and infectious ...

Good morning, Chicago. Colder temperatures are fast approaching, and for many of us it raises an important question when we start to feel under the weather: Is it a seasonal ...

Citigroup CEO Jane Fraser was elected as chair of the board of directors, the bank said in a filing on Wednesday.

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Pfizer, Inc. CEO Albert Bourla said on Tuesday that the U.S. pharmaceutical industry should work more collaboratively with ...

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

AstraZeneca broke ground on a new plant in Virginia on Thursday and said it would spend $4.5 billion on the facility as drugmakers look to respond to President Donald Trump's call for more medicines ...

Agreement includes 'most-favored-nation' pricing for the Medicaid program and direct-sale website discounts. (HealthDay News) — The White House has struck a deal with pharmaceutical giant Pfizer Inc.

By stepping out as the first biopharma to win a three-year exemption from President Donald Trump’s earlier-announced plans for 100% tariffs, in return for agreeing to manufacture more of its drugs in ...

Journal Editorial Report: Trump unveils ‘Trump Rx’ and makes a deal with Pfizer. Pfizer CEO Albert Bourla earned $24.6 million in compensation last year. Despite his company’s sagging share price and ...

Shares of the pharmaceutical giant have been in the red for three consecutive years. It just reached a deal with the White House that will give it a three-year grace period on tariffs. Acquisitions ...